Aging, Aging Well
Conditions
Brief summary
This is a prospective, single group, self-controlled study to evaluate the clinical and molecular impact of continuous in-home resonance-based electromagnetic field (EMF) protection device usage in healthy individuals.
Interventions
DEVICEIn-home resonance-based electromagnetic field protection device
Participants will have an in-home EMF protection device
Sponsors
Blushield USA
TruDiagnostic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Any sex, gender orientation, and ethnicity * Between ages 30 and 70 * Must be willing and able to participate in venipuncture, health history and clinical assessments, passive monitoring (Oura ring), and continuous in-home Blushield device usage
Exclusion criteria
* Significant change in diagnosis and/or treatment of major illness or injury within 2 years prior to screening, e.g., diabetes, cancer, cardiovascular disease, psychiatric condition 2. Any ongoing immune system concerns or immunodeficiency disease * History of any viral illness in preceding year * Body mass index (BMI) \> 35 kg/m2 * Presence of active infection * Any other illness, disorder, alcohol or chemical dependence that in the opinion of investigators would render study participation unsuitable * Unable or unwilling to provide required biological sample * Unable or unwilling to avoid pregnancy during study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Epigenetic Testing | Change from baseline to 12 weeks |
Contacts
Primary ContactNatalie Amalani
Backup ContactAnnie Prestrud
Outcome results
None listed